Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 5
1968 8
1969 15
1970 15
1971 17
1972 23
1973 17
1974 20
1975 24
1976 42
1977 30
1978 44
1979 46
1980 56
1981 102
1982 131
1983 224
1984 290
1985 286
1986 289
1987 260
1988 242
1989 254
1990 246
1991 236
1992 252
1993 226
1994 197
1995 214
1996 248
1997 242
1998 228
1999 256
2000 281
2001 256
2002 289
2003 328
2004 291
2005 311
2006 359
2007 324
2008 335
2009 303
2010 366
2011 375
2012 359
2013 345
2014 352
2015 337
2016 373
2017 327
2018 346
2019 354
2020 387
2021 369
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

11,510 results
Results by year
Filters applied: . Clear all
Page 1
[Clinical aspects of treatment with amiodarone].
Haverkamp W, Israel C, Parwani A. Haverkamp W, et al. Herzschrittmacherther Elektrophysiol. 2017 Sep;28(3):307-316. doi: 10.1007/s00399-017-0516-0. Herzschrittmacherther Elektrophysiol. 2017. PMID: 28643175 Review. German.
Proarrhythmic effects of amiodarone in patients with structural heart disease are rare. However, extracardiac adverse effects occurring in association with amiodarone treatment are frequent and feared. ...This paper discusses recommendations regarding the monitoring …
Proarrhythmic effects of amiodarone in patients with structural heart disease are rare. However, extracardiac adverse effects occurri …
Pharmacology and pharmacokinetics of amiodarone.
Freedman MD, Somberg JC. Freedman MD, et al. J Clin Pharmacol. 1991 Nov;31(11):1061-9. doi: 10.1002/j.1552-4604.1991.tb03673.x. J Clin Pharmacol. 1991. PMID: 1753010 Review.
Amiodarone is a unique antiarrhythmic agent originally developed as a vasodilator. ...A pharmacokinetically based loading scheme is described, and data suggesting a role for routine amiodarone plasma levels are presented....
Amiodarone is a unique antiarrhythmic agent originally developed as a vasodilator. ...A pharmacokinetically based loading scheme is d
Acute Amiodarone Pulmonary Toxicity.
Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Feduska ET, et al. J Cardiothorac Vasc Anesth. 2021 May;35(5):1485-1494. doi: 10.1053/j.jvca.2020.10.060. Epub 2020 Nov 5. J Cardiothorac Vasc Anesth. 2021. PMID: 33262034 Review.
Amiodarone possesses a significant adverse reaction profile. Amiodarone-induced pulmonary toxicity (AIPT) is among the most serious adverse effects and is a leading cause of death associated with its use. ...Acute respiratory distress syndrome (ARDS) is the predomin
Amiodarone possesses a significant adverse reaction profile. Amiodarone-induced pulmonary toxicity (AIPT) is among the most se
[Amiodarone].
Stäubli M. Stäubli M. Schweiz Med Wochenschr. 1988 Dec 17;118(50):1871-80. Schweiz Med Wochenschr. 1988. PMID: 3065934 Review. German.
Replacement of amiodarone by another antiarrhythmic drug in the same patient may be problematic, because pharmacokinetic and pharmacodynamic interactions of residual amiodarone with the new antiarrhythmic drug are to be expected. Therefore, amiodarone should …
Replacement of amiodarone by another antiarrhythmic drug in the same patient may be problematic, because pharmacokinetic and pharmaco …
Amiodarone.
Smith WC, Reddy CP. Smith WC, et al. J La State Med Soc. 1989 May;141(5):35-8. J La State Med Soc. 1989. PMID: 2659709 Review.
Amiodarone is an antiarrhythmic agent with unique electrophysiological and pharmacokinetic properties and a wide spectrum of antiarrhythmic activity. Its clinical efficacy is not confined to ventricular arrhythmias but extends to supraventricular arrhythmias including thos
Amiodarone is an antiarrhythmic agent with unique electrophysiological and pharmacokinetic properties and a wide spectrum of antiarrh
[Treatment with amiodarone].
Adelborg K, Ebbehøj E, Nielsen JC, Grove EL. Adelborg K, et al. Ugeskr Laeger. 2015 Jun 8;177(24):1168-71. Ugeskr Laeger. 2015. PMID: 26554056 Review. Danish.
Amiodarone is an effective antiarrhythmic drug for supraventricular and ventricular arrhythmias. A majority of patients treated with amiodarone suffer from mild adverse events, however, serious life-threatening adverse events caused by amiodarone are also see
Amiodarone is an effective antiarrhythmic drug for supraventricular and ventricular arrhythmias. A majority of patients treated with
Dronedarone.
Hoy SM, Keam SJ. Hoy SM, et al. Drugs. 2009 Aug 20;69(12):1647-63. doi: 10.2165/11200820-000000000-00000. Drugs. 2009. PMID: 19678715 Review.
Oral dronedarone is a non-iodinated benzofurane derivative structurally related to amiodarone. Although it is considered a class III antiarrhythmic agent like amiodarone, it demonstrates multi-class electrophysiological activity. ...
Oral dronedarone is a non-iodinated benzofurane derivative structurally related to amiodarone. Although it is considered a class III …
[Amiodarone].
Hein L. Hein L. Dtsch Med Wochenschr. 2001 May 25;126(21):625-6. doi: 10.1055/s-2001-14417. Dtsch Med Wochenschr. 2001. PMID: 11413750 Review. German. No abstract available.
Amiodarone.
Mason JW. Mason JW. N Engl J Med. 1987 Feb 19;316(8):455-66. doi: 10.1056/NEJM198702193160807. N Engl J Med. 1987. PMID: 3543680 Review. No abstract available.
[AMIODARONE AND THE THYROID FUNCTION].
Jukić T, Punda M, Franceschi M, Staniĉić J, Granić R, Kusić Z. Jukić T, et al. Lijec Vjesn. 2015 May-Jun;137(5-6):181-8. Lijec Vjesn. 2015. PMID: 26380478 Review. Croatian.
Amiodarone is a benzofuran derivative that contains up to 40% of iodine. ...AIT II is treated with glucocorticoids. Patients with AIT have to stop treatment with amiodarone. Dronedarone is a less potent antiarrhythmic agent with structural and pharmacological proper
Amiodarone is a benzofuran derivative that contains up to 40% of iodine. ...AIT II is treated with glucocorticoids. Patients with AIT
11,510 results
You have reached the last available page of results. Please see the User Guide for more information.